1 / 7

Confidential - Proprietary information of El-Vision Ltd . Contact:

Introducing Technology Preserving Sight for Everyone. Confidential - Proprietary information of El-Vision Ltd . Contact: Mr. Arthur Rabner: 42 Ha-Rakevet Str, Tel-Aviv 67770, Israel. arthur@el-vision.com +972-54-4447948. Operation Started: Aug 2006 CEO: Mr. Tal Dilian

alohilani
Download Presentation

Confidential - Proprietary information of El-Vision Ltd . Contact:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Introducing Technology Preserving Sight for Everyone Confidential - Proprietary information of El-Vision Ltd. Contact: Mr. Arthur Rabner: 42 Ha-Rakevet Str, Tel-Aviv 67770, Israel. arthur@el-vision.com +972-54-4447948

  2. Operation Started: Aug 2006 CEO:Mr. Tal Dilian CTO and Founder:Mr. Arthur Rabner Financing: About $1M (IL OCS, IL/US Private) Full Time Employees: 6 The Company 2

  3. Ophthalmic Arena Bottlenecks Underserved Populations (aging, diabetes, low awareness/income, remote areas) Today Vision Screening services are not effective (mismatching ~30% - 60% of cases) Tight Competition between Eye Care Professionals (50,000 in US ) Tight Competition on High End Diagnostics Instruments Market (Total $1.5B in US, 10% growth) 3

  4. The El-Vision Solution OcuTest3 The Vision of Final Device Patient under Test Eye care assistant Examination is performed in an office or in any other place Eye Care office with plug-in El-Vision’s SW into EMR Communication Link All-In-One Device for High-End Vision & Eyes Screening During 5 – 15 minutes 4

  5. El-Vision’s Opportunity Old Players Startups Leaders El-Vision Leaders Leaders Old Players Startups Old Players Sales Growth Competition High End: ( > $25K ) Low End (< $5K) Med Range (<$25K) High End Vision & Eyes Screener Optometrists Ophthalmologists Vision Screeners New Players Primary Care Physicians Increased Demand Ophthalmic Assistants delegate Ophthalmic Assistants Optometrists Ophthalmologists Optometrists Ophthalmologists Specific Disease Experts Specific Disease Experts delegate specialization Extended Audience Fight for customers • Special Eye Care • Follow-up • Special Eye Care • Follow-up Comprehensive Vision & Eyes Screening • Prescription • Primary Eye Care • Follow-up Preliminary exam refer Treated Prompt Cheap Remote direct More More promotion Manufacturers High End: ( > $25K ) Instruments $1.5B/year in US 10% growth 150,000 50,000 Users Optometrists Ophthalmologists Population ================= • Prescription • Primary Eye Care • Follow-up General ODs / OMDs Users Treated Underserved 5

  6. El-Vision: 12 months Milestones / Financials VATest-rev2 part1 part2 part3 part3 (in US) VATest FDA Application Prototype VATest-rev3/4 VATest Production Version Clinical Studies Regulation Activities Funds Raising $1M raising VC/Corporate Funds Raising (round A) Dec08 Jan09 Feb09 Mar09 Jun09 Jul09 Sep08 Oct08 Nov08 Apr09 May09 Aug09 Proceeds $1,040,000 6

  7. Thank you More detailed information is available, please contact the CTO of El-Vision, Arthur Rabner: arthur@el-vision.com

More Related